241 related articles for article (PubMed ID: 10803526)
1. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation.
Yagita M; Huang CL; Umehara H; Matsuo Y; Tabata R; Miyake M; Konaka Y; Takatsuki K
Leukemia; 2000 May; 14(5):922-30. PubMed ID: 10803526
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection.
Tsuchiyama J; Yoshino T; Mori M; Kondoh E; Oka T; Akagi T; Hiraki A; Nakayama H; Shibuya A; Ma Y; Kawabata T; Okada S; Harada M
Blood; 1998 Aug; 92(4):1374-83. PubMed ID: 9694726
[TBL] [Abstract][Full Text] [Related]
3. Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma.
Drexler HG; Matsuo Y
Leukemia; 2000 May; 14(5):777-82. PubMed ID: 10803505
[TBL] [Abstract][Full Text] [Related]
4. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
Robertson MJ; Cochran KJ; Cameron C; Le JM; Tantravahi R; Ritz J
Exp Hematol; 1996 Feb; 24(3):406-15. PubMed ID: 8599969
[TBL] [Abstract][Full Text] [Related]
6. Novel leukemic lymphoma with probable derivation from immature stage of natural killer (NK) lineage in an aged patient.
Kawano S; Tatsumi E; Yoneda N; Yamaguchi N; Goji J; Ito H; Nagai T; Nishikori M; Okamura A; Koiwai O
Hematol Oncol; 1995; 13(1):1-11. PubMed ID: 7538482
[TBL] [Abstract][Full Text] [Related]
7. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
[TBL] [Abstract][Full Text] [Related]
8. Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma.
Matsuo Y; Drexler HG
Leuk Res; 2003 Oct; 27(10):935-45. PubMed ID: 12860014
[TBL] [Abstract][Full Text] [Related]
9. Morphological, phenotypic and functional characteristics of a pure population of CD56+ CD16- CD3- large granular lymphocytes generated from human duodenal mucosa.
Pang G; Buret A; Batey RT; Chen QY; Couch L; Cripps A; Clancy R
Immunology; 1993 Jul; 79(3):498-505. PubMed ID: 7691728
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells.
Gong JH; Maki G; Klingemann HG
Leukemia; 1994 Apr; 8(4):652-8. PubMed ID: 8152260
[TBL] [Abstract][Full Text] [Related]
11. Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection.
Oyoshi MK; Nagata H; Kimura N; Zhang Y; Demachi A; Hara T; Kanegane H; Matsuo Y; Yamaguchi T; Morio T; Hirano A; Shimizu N; Yamamoto K
Am J Pathol; 2003 May; 162(5):1629-38. PubMed ID: 12707047
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a new natural killer (NK) cell line, TKS-1, from a patient with aggressive type of large granular lymphocyte (LGL) leukemia.
Kojima H; Suzukawa K; Yatabe Y; Hori M; Nagasawa T; Abe T
Leukemia; 1994 Nov; 8(11):1999-2004. PubMed ID: 7967745
[TBL] [Abstract][Full Text] [Related]
13. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
14. Aggressive variant of morphologically typical T large granular lymphocyte leukemia/lymphoma lacking NK cell markers.
Passetto Falcão R; Pinto Simões B; Garcia AB; Fonseca BA; Terra Filho J
Acta Haematol; 2000; 104(2-3):110-4. PubMed ID: 11154985
[TBL] [Abstract][Full Text] [Related]
15. Establishment of an IL-2-dependent cell line derived from 'nasal-type' NK/T-cell lymphoma of CD2+, sCD3-, CD3epsilon+, CD56+ phenotype and associated with the Epstein-Barr virus.
Kagami Y; Nakamura S; Suzuki R; Iida S; Yatabe Y; Okada Y; Kobayashi T; Tsurumi T; Seto M; Ogura M; Taguchi O; Morishima Y
Br J Haematol; 1998 Dec; 103(3):669-77. PubMed ID: 9858215
[TBL] [Abstract][Full Text] [Related]
16. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.
Suzuki R; Yamamoto K; Seto M; Kagami Y; Ogura M; Yatabe Y; Suchi T; Kodera Y; Morishima Y; Takahashi T; Saito H; Ueda R; Nakamura S
Blood; 1997 Sep; 90(6):2417-28. PubMed ID: 9310493
[TBL] [Abstract][Full Text] [Related]
17. Establishment of the T-cell large granular lymphocyte leukemia cell line MOTN-1 carrying natural killer-cell antigens.
Matsuo Y; Drexler HG; Takeuchi M; Tanaka M; Orita K
Leuk Res; 2002 Sep; 26(9):873-9. PubMed ID: 12127564
[TBL] [Abstract][Full Text] [Related]
18. A child case of CD34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement.
Nagata T; Higashigawa M; Nagai M; Zhang XL; Azuma E; Komada Y; Sakurai M
Leuk Res; 1996; 20(11-12):983-5. PubMed ID: 9009257
[TBL] [Abstract][Full Text] [Related]
19. Production of proinflammatory cytokines without invocation of cytotoxic effects by an Epstein-Barr virus-infected natural killer cell line established from a patient with hypersensitivity to mosquito bites.
Suzuki D; Tsuji K; Yamamoto T; Fujii K; Iwatsuki K
Exp Hematol; 2010 Oct; 38(10):933-44. PubMed ID: 20600581
[TBL] [Abstract][Full Text] [Related]
20. Aggressive natural killer cell lymphoma/leukemia. A recently recognized clinicopathologic entity.
Sun T; Brody J; Susin M; Marino J; Teichberg S; Koduru P; Hall WW; Urmacher C; Hajdu SI
Am J Surg Pathol; 1993 Dec; 17(12):1289-99. PubMed ID: 8238737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]